BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26543360)

  • 1. The stats are in: an update on statin use in COPD.
    Carlson AA; Smith EA; Reid DJ
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2277-84. PubMed ID: 26543360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the potential role of statins in chronic obstructive pulmonary disease and its co-morbidities.
    Young RP; Hopkins RJ
    Expert Rev Respir Med; 2013 Oct; 7(5):533-44. PubMed ID: 24138695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Studies of Statins in Asthma and COPD.
    Thomson NC
    Curr Mol Pharmacol; 2017; 10(1):60-71. PubMed ID: 26758945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin Effects on Exacerbation Rates, Mortality, and Inflammatory Markers in Patients with Chronic Obstructive Pulmonary Disease: A Review of Prospective Studies.
    Howard ML; Vincent AH
    Pharmacotherapy; 2016 May; 36(5):536-47. PubMed ID: 26990316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.
    Mancini GB; Etminan M; Zhang B; Levesque LE; FitzGerald JM; Brophy JM
    J Am Coll Cardiol; 2006 Jun; 47(12):2554-60. PubMed ID: 16781387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosuvastatin treatment in stable chronic obstructive pulmonary disease (RODEO): a randomized controlled trial.
    Neukamm A; Høiseth AD; Einvik G; Lehmann S; Hagve TA; Søyseth V; Omland T
    J Intern Med; 2015 Jul; 278(1):59-67. PubMed ID: 25495178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are Statins out in the COLD? The STATCOPE Trial.
    Mancini GB; Road J
    Can J Cardiol; 2015 Aug; 31(8):970-3. PubMed ID: 26117620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins reduce the burden of ambient particulate matter and inflammatory cells within the lung tissues of smokers with and without COPD.
    Hiraiwa K; Miller S; Ngan DA; Vasilescu DM; Hackett TL; Kinose D; Cheng JC; van Eeden SF
    Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 28049173
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological actions of statins: potential utility in COPD.
    Young RP; Hopkins R; Eaton TE
    Eur Respir Rev; 2009 Dec; 18(114):222-32. PubMed ID: 20956147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin use and risk of COPD exacerbation requiring hospitalization.
    Wang MT; Lo YW; Tsai CL; Chang LC; Malone DC; Chu CL; Liou JT
    Am J Med; 2013 Jul; 126(7):598-606.e2. PubMed ID: 23684060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study.
    Blamoun AI; Batty GN; DeBari VA; Rashid AO; Sheikh M; Khan MA
    Int J Clin Pract; 2008 Sep; 62(9):1373-8. PubMed ID: 18422598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins as adjunct therapy in COPD: how do we cope after STATCOPE?
    Young RP; Hopkins RJ; Agusti A
    Thorax; 2014 Oct; 69(10):891-4. PubMed ID: 25015240
    [No Abstract]   [Full Text] [Related]  

  • 13. Statin use and exacerbations in individuals with chronic obstructive pulmonary disease.
    Ingebrigtsen TS; Marott JL; Nordestgaard BG; Lange P; Hallas J; Vestbo J
    Thorax; 2015 Jan; 70(1):33-40. PubMed ID: 25349333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin use is associated with reduced mortality in COPD.
    Søyseth V; Brekke PH; Smith P; Omland T
    Eur Respir J; 2007 Feb; 29(2):279-83. PubMed ID: 17050558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of statins in chronic obstructive pulmonary disease: is cardiovascular disease the common denominator?
    Amariei DE; Reed RM
    Curr Opin Pulm Med; 2019 Mar; 25(2):173-178. PubMed ID: 30418244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence.
    Young RP; Hopkins R; Eaton TE
    Postgrad Med J; 2009 Aug; 85(1006):414-21. PubMed ID: 19633007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin use and hospitalization in patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study in Taiwan.
    Huang CC; Chan WL; Chen YC; Chen TJ; Chou KT; Lin SJ; Chen JW; Leu HB
    Clin Ther; 2011 Oct; 33(10):1365-70. PubMed ID: 21962452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins and outcome after hospitalization for COPD exacerbation: a prospective study.
    Bartziokas K; Papaioannou AI; Minas M; Kostikas K; Banya W; Daniil ZD; Haniotou A; Gourgoulianis KI
    Pulm Pharmacol Ther; 2011 Oct; 24(5):625-31. PubMed ID: 21729761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins in COPD: a systematic review.
    Janda S; Park K; FitzGerald JM; Etminan M; Swiston J
    Chest; 2009 Sep; 136(3):734-743. PubMed ID: 19376844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in mortality rate of chronic obstructive pulmonary disease (COPD) with statin use: a population-based analysis in Japan.
    Ishida W; Kajiwara T; Ishii M; Fujiwara F; Taneichi H; Takebe N; Takahashi K; Kaneko Y; Segawa I; Inoue H; Satoh J
    Tohoku J Exp Med; 2007 Jul; 212(3):265-73. PubMed ID: 17592214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.